Literature DB >> 24102908

The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.

Gabriela Avram1, Beatriz Sánchez-Sendra, José M Martín, Liria Terrádez, David Ramos, Carlos Monteagudo.   

Abstract

AIMS: Tumour-infiltrating lymphocytes have prognostic value in malignant melanoma. High endothelial venules (HEVs) are specialized vessels present in lymph nodes and tertiary lymphoid organs. CCL19, CCL21 and CCR7 regulate lymphocyte migration through HEVs. The aim of our study was to correlate HEV density in cutaneous primary and metastatic malignant melanomas with clinicopathological parameters, and with CCL19, CCL21 and CCR7 mRNA expression. METHODS AND
RESULTS: High endothelial venule density was evaluated by immunohistochemistry with a specific antibody, MECA-79, and chemokine expression was evaluated by real-time PCR. MECA-79-positive vessels, covered by cuboidal (C-HEV) or flat (F-HEV) endothelium, were detected in 55% of melanomas. HEV density was higher in primary melanomas than in metastases. Positive correlations were found between C-HEV density and lymphocytic infiltration, and between F-HEV density and tumour regression. Cases in which the number of C-HEVs exceeded that of F-HEVs had higher levels of CCL19, CCL21, and CCR7.
CONCLUSIONS: Our results support a predominant role for C-HEV in the recruitment of lymphocytes in cutaneous melanomas, mediated by CCL19 and CCL21, whereas the density of F-HEV strongly correlates with tumour regression, Therefore, cuboidal and flat HEVs may serve as indicators of the active and late quiescent phases, respectively, of tumour regression in cutaneous malignant melanoma.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  CC-chemokine ligand 19; CC-chemokine ligand 21; MECA-79; chemokine CC-receptor 7; chemokines; high endothelial venules; melanoma; regression; tumour-infiltrating lymphocyte

Mesh:

Substances:

Year:  2013        PMID: 24102908     DOI: 10.1111/his.12235

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  22 in total

Review 1.  B cells and antibody production in melanoma.

Authors:  Jessica Da Gama Duarte; Janique M Peyper; Jonathan M Blackburn
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

2.  Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.

Authors:  Yu Zhang; Fei Wang; Hao-Ran Sun; Ya-Kai Huang; Jian-Peng Gao; Hua Huang
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-23       Impact factor: 4.553

Review 3.  Apatinib: A Novel Antiangiogenic Drug in Monotherapy or Combination Immunotherapy for Digestive System Malignancies.

Authors:  Haosheng Li; Haiyan Huang; Tao Zhang; Haoran Feng; Shaodong Wang; Yaqi Zhang; Xiaopin Ji; Xi Cheng; Ren Zhao
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

4.  Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival.

Authors:  Junko Sawada; Nobuyoshi Hiraoka; Rongsu Qi; Lu Jiang; Ashley E Fournier-Goss; Masayuki Yoshida; Hiroto Kawashima; Masanobu Komatsu
Journal:  Cancer Immunol Res       Date:  2022-04-01       Impact factor: 12.020

5.  Presence of tumour high-endothelial venules is an independent positive prognostic factor and stratifies patients with advanced-stage oral squamous cell carcinoma.

Authors:  Anna M Wirsing; Oddveig G Rikardsen; Sonja E Steigen; Lars Uhlin-Hansen; Elin Hadler-Olsen
Journal:  Tumour Biol       Date:  2015-09-17

Review 6.  Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment.

Authors:  J David Peske; Amber B Woods; Victor H Engelhard
Journal:  Adv Cancer Res       Date:  2015-06-01       Impact factor: 6.242

7.  High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression.

Authors:  Diana Costa Bento; Emma Jones; Syed Junaid; Justyna Tull; Geraint T Williams; Andrew Godkin; Ann Ager; Awen Gallimore
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

8.  High Endothelial Venules Accelerate Naive T Cell Recruitment by Tumor Necrosis Factor-Mediated R-Ras Upregulation.

Authors:  Junko Sawada; Carole Y Perrot; Linyuan Chen; Ashley E Fournier-Goss; Jeremiah Oyer; Alicja Copik; Masanobu Komatsu
Journal:  Am J Pathol       Date:  2020-11-04       Impact factor: 4.307

Review 9.  The Dual Role of High Endothelial Venules in Cancer Progression versus Immunity.

Authors:  Stefan Milutinovic; Jun Abe; Andrew Godkin; Jens V Stein; Awen Gallimore
Journal:  Trends Cancer       Date:  2020-10-31

10.  B cells and tertiary lymphoid structures promote immunotherapy response.

Authors:  Beth A Helmink; Sangeetha M Reddy; Jianjun Gao; Shaojun Zhang; Rafet Basar; Rohit Thakur; Keren Yizhak; Moshe Sade-Feldman; Jorge Blando; Guangchun Han; Vancheswaran Gopalakrishnan; Yuanxin Xi; Hao Zhao; Rodabe N Amaria; Hussein A Tawbi; Alex P Cogdill; Wenbin Liu; Valerie S LeBleu; Fernanda G Kugeratski; Sapna Patel; Michael A Davies; Patrick Hwu; Jeffrey E Lee; Jeffrey E Gershenwald; Anthony Lucci; Reetakshi Arora; Scott Woodman; Emily Z Keung; Pierre-Olivier Gaudreau; Alexandre Reuben; Christine N Spencer; Elizabeth M Burton; Lauren E Haydu; Alexander J Lazar; Roberta Zapassodi; Courtney W Hudgens; Deborah A Ledesma; SuFey Ong; Michael Bailey; Sarah Warren; Disha Rao; Oscar Krijgsman; Elisa A Rozeman; Daniel Peeper; Christian U Blank; Ton N Schumacher; Lisa H Butterfield; Monika A Zelazowska; Kevin M McBride; Raghu Kalluri; James Allison; Florent Petitprez; Wolf Herman Fridman; Catherine Sautès-Fridman; Nir Hacohen; Katayoun Rezvani; Padmanee Sharma; Michael T Tetzlaff; Linghua Wang; Jennifer A Wargo
Journal:  Nature       Date:  2020-01-15       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.